12,342 Shares in Core Scientific, Inc. (NASDAQ:CORZ) Bought by Amalgamated Bank

Amalgamated Bank purchased a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ) in the second quarter, Holdings Channel reports. The fund purchased 12,342 shares of the company’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. acquired a new position in Core Scientific during the first quarter valued at $21,973,000. Hexagon Capital Partners LLC purchased a new position in Core Scientific in the 1st quarter valued at $34,000. Blair William & Co. IL acquired a new stake in Core Scientific during the 1st quarter worth $1,156,000. Central Asset Investments & Management Holdings HK Ltd purchased a new stake in shares of Core Scientific during the second quarter worth $1,218,000. Finally, Vident Advisory LLC purchased a new position in shares of Core Scientific in the first quarter worth about $4,047,000.

Core Scientific Trading Down 0.8 %

Core Scientific stock opened at $11.76 on Wednesday. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $12.95. The stock has a 50-day moving average price of $10.36 and a 200 day moving average price of $7.44.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($4.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The firm had revenue of $141.10 million for the quarter, compared to the consensus estimate of $128.58 million. Core Scientific’s revenue was up 11.2% compared to the same quarter last year. As a group, equities research analysts expect that Core Scientific, Inc. will post 0.01 earnings per share for the current year.

Insider Activity

In related news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $108,986.62. Following the completion of the sale, the insider now owns 1,686,474 shares of the company’s stock, valued at approximately $15,869,720.34. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $108,986.62. Following the completion of the transaction, the insider now directly owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Jarrod M. Patten purchased 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was bought at an average price of $9.70 per share, with a total value of $38,800.00. Following the purchase, the director now owns 279,239 shares of the company’s stock, valued at approximately $2,708,618.30. The disclosure for this purchase can be found here. Insiders have bought 12,761 shares of company stock valued at $127,080 in the last three months. Corporate insiders own 32.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on CORZ shares. Canaccord Genuity Group began coverage on shares of Core Scientific in a research report on Monday, September 23rd. They set a “buy” rating and a $16.00 price target on the stock. HC Wainwright raised their price objective on Core Scientific from $11.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Cantor Fitzgerald restated an “overweight” rating and set a $20.00 price target on shares of Core Scientific in a research note on Tuesday, September 3rd. Needham & Company LLC began coverage on Core Scientific in a research report on Wednesday, September 4th. They set a “buy” rating and a $16.00 price target on the stock. Finally, B. Riley upgraded shares of Core Scientific from a “neutral” rating to a “buy” rating and increased their target price for the stock from $0.50 to $13.00 in a research note on Wednesday, July 17th. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Core Scientific has an average rating of “Buy” and an average target price of $15.18.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.